Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01102036
Other study ID # C-X-Ray U-09-017
Secondary ID
Status Completed
Phase N/A
First received April 8, 2010
Last updated August 25, 2011
Start date February 2010
Est. completion date June 2010

Study information

Verified date April 2010
Source Good Food Practice, Sweden
Contact n/a
Is FDA regulated No
Health authority Sweden: Regional Ethical Review Board
Study type Interventional

Clinical Trial Summary

The aim of this study is to determine the effect of cultura yoghurt on transit time and digestive discomfort during 2 weeks of treatment in comparison to placebo in healthy women and men.


Description:

Transit time is the time it takes for a substance to pass through the gut. The major part of the transit is spent in the large bowel is therefore mainly a colonic event. It has been observed that slow transit time is associated with high prevalence of large bowel disorders. The objectives of this study is to:

- determine the effect on mean transit time after 2 weeks intake of a investigational products using radio-opaque sulphate impregnated polyethylene pellets as markers.

- determine effect of investigational products on total symptom score according to Bristol Stool Form (BSF)

- determine effect of investigational products in gastrointestinal symptoms

- determine safety of intake of the investigational products


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date June 2010
Est. primary completion date May 2010
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

- Female and Males

- Healthy

- BMI 19-29 at visit 1

- Age 18 and 60 years at visit 1

- Defecation 3-4 times per week or every second to third day (Bristol Stool Form) during the run-in

- Transit time 35 and 72 hours calculated from the abdominal X-ray at visit 3

- Signed written informed consent

Exclusion Criteria:

- Use of probiotics food or supplements during the study

- Past history of digestive disease

- Previous complicated GI surgery

- Oral use of antimicrobial medication or antimicrobial prophylaxis 4 weeks prior to screening visit

- Use of laxatives (medication or dietary supplements) during the study.

- Pregnant or lactating or wish to become pregnant during the period of the study

- Lack of suitability for participation in the trial, for any reason, as judged by the personnel at KPL Good Food Practice AB

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
Cultura L casei F19, acidophilus La5 , B lactis Bb 12
2 weeks consumption,250 ml/day
Yoghurt without probiotics
Yoghurt without probiotics

Locations

Country Name City State
Sweden Good Food Practice Uppsala

Sponsors (2)

Lead Sponsor Collaborator
Good Food Practice, Sweden Arla Foods

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in transit time between treatments To determine the effect on mean transit time after 2 weeks intake of investigational products using radio-opaque barium sulphate impregnated polyethylen capsules. These capsules will be consumed during 3 days and thereafter an x-ray image will be taken over the bowel. The capsulese will then be calculated to determine the colonic transit time February 2010-June 2010 Yes
Secondary Change between treatments on Bristol Stool Form (BSF)symptoms scores To determine the effect of Cultura yoghurt on the total symptom score according to Bristol Stool Form (BSF) scale during 2 weeks of treatment in comparison to placebo in healthy women and men February 2010-June2010 No
Secondary Change between treatments on gastrointestinal symptoms according to Bristol Stool Form To determine the effect of Cultura yoghurt on gastrointestinal symptoms according to the Bristol Stool Form (BSF) after 2 weeks treatment of investigational products February 2010-June 2010 No
See also
  Status Clinical Trial Phase
Completed NCT05517460 - The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center N/A
Recruiting NCT06292949 - Clinical Study of Resistant Starch in Improving Constipation N/A
Recruiting NCT04132661 - MRI Assessment of Mode of Action of Bisacodyl, Single Dose Phase 4
Completed NCT02726295 - The Efficacy of Mutaflor(E. Coli Nissle 1917, Mutaflor®) for Chronic Constipation:Multicenter Study Phase 4
Terminated NCT02839889 - Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation) Phase 4
Recruiting NCT02255747 - Anal Dilatation for Infants and Children With Constipation N/A
Completed NCT02246647 - Biomarkers for Intestinal Permeability in Patients With Constipation
Completed NCT01566409 - Maintenance Treatment for Children With Constipation N/A
Completed NCT02658201 - Ultrafast MRI Imaging to Exclude Constipation N/A
Completed NCT01695915 - Diurnal Variation in Rectal Diameter N/A
Completed NCT02863848 - Effect of Inulin-type Fructans on Constipated Children. N/A
Completed NCT01710579 - Normal Values in Ano-rectal 3D High Resolution Manometry N/A
Completed NCT01474499 - A Trial of Docusate Sodium and Sorbitol Rectal Solution for the in Patients With Constipation Phase 3
Completed NCT01438567 - A Study to Demonstrate Improvement in Symptoms of Constipation in Subjects That Require Around-the-clock Opioid Pain Killer Therapy Phase 3
Completed NCT01411501 - Efficacy and Safety of Acupuncture for Functional Constipation Phase 3
Completed NCT01170039 - The Effectiveness of Lubiprostone in Constipated Diabetics Phase 4
Completed NCT00931853 - Efficacy and Tolerability of Cassia Fistula Plus Senna Alexandrina Miller (Sugar Free) in the Chronic Functional Constipation (CFC). Phase 3
Active, not recruiting NCT02442115 - Impact of Improving GI Symptoms on Autism Symptoms and Oxidative Stress
Completed NCT00994851 - Evaluation of Cassia Fistula + Senna Alexandrina Miller in the Chronic Functional Constipation Treatment. Phase 3
Terminated NCT01003249 - Dysfunctional Voiding and Lower Urinary Tract Symptoms With Baclofen Phase 4